{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T17:10:09Z","timestamp":1726593009113},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,17]]},"DOI":"10.7759\/cureus.69588","type":"journal-article","created":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T16:28:53Z","timestamp":1726590533000},"source":"Crossref","is-referenced-by-count":0,"title":["Immunological Enigma: A Case Report of COVID-19 Survival in a Patient With Human Immunodeficiency Virus, Hepatitis C Virus, and Tuberculosis Co-infection"],"prefix":"10.7759","author":[{"given":"Martina","family":"Bozhkova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steliyan","family":"Petrov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanya","family":"Velyanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariyana","family":"Stoycheva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianna","family":"Murdjeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004086","article-title":"Outcome of COVID-19 in hospitalised immunocompromised patients: an analysis of the WHO ISARIC CCP-UK prospective cohort study","volume":"20","author":"Turtle L","year":"2023","unstructured":"Turtle L, Thorpe M, Drake TM, et al.. Outcome of COVID-19 in hospitalised immunocompromised patients: an analysis of the WHO ISARIC CCP-UK prospective cohort study. PLoS Med. 2023, 20:e1004086. 10.1371\/journal.pmed.1004086","journal-title":"PLoS Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.14900","article-title":"Unveiling COVID-19 treatment strategies for immunocompromised individuals: therapeutic innovations and latest findings","volume":"27","author":"Liu LT","year":"2024","unstructured":"Liu LT, Tsai JJ. Unveiling COVID-19 treatment strategies for immunocompromised individuals: therapeutic innovations and latest findings. Int J Rheum Dis. 2024, 27:e14900. 10.1111\/1756-185X.14900","journal-title":"Int J Rheum Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1441199","article-title":"Editorial: therapeutic management of COVID-19 in immunocompromised patients and interaction with the immune response: from preventive to curative strategies","volume":"15","author":"Benotmane I","year":"2024","unstructured":"Benotmane I, Solis M. Editorial: therapeutic management of COVID-19 in immunocompromised patients and interaction with the immune response: from preventive to curative strategies. Front Immunol. 2024, 15:1441199. 10.3389\/fimmu.2024.1441199","journal-title":"Front Immunol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2022.11.012","article-title":"Coronavirus disease-2019 in the immunocompromised host","volume":"44","author":"Bertini CD Jr","year":"2023","unstructured":"Bertini CD Jr, Khawaja F, Sheshadri A. Coronavirus disease-2019 in the immunocompromised host. Clin Chest Med. 2023, 44:395-406. 10.1016\/j.ccm.2022.11.012","journal-title":"Clin Chest Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/S11095-018-2528-9\/FIGURES\/3.","article-title":"Mycobacterium tuberculosis and interactions with the host immune system: opportunities for nanoparticle based immunotherapeutics and vaccines","volume":"36","author":"Bekale RB","year":"2019","unstructured":"Bekale RB, Du Plessis SM, Hsu NJ, et al.. Mycobacterium tuberculosis and interactions with the host immune system: opportunities for nanoparticle based immunotherapeutics and vaccines. Pharm Res. 2019, 36:1-15. 10.1007\/S11095-018-2528-9\/FIGURES\/3.","journal-title":"Pharm Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2019.00350","article-title":"Immune response to Mycobacterium tuberculosis: a narrative review","volume":"7","author":"de Martino M","year":"2019","unstructured":"de Martino M, Lodi L, Galli L, Chiappini E. Immune response to Mycobacterium tuberculosis: a narrative review. Front Pediatr. 2019, 7:350. 10.3389\/fped.2019.00350","journal-title":"Front Pediatr"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-022-00763-4","article-title":"Immune evasion and provocation by Mycobacterium tuberculosis","volume":"20","author":"Chandra P","year":"2022","unstructured":"Chandra P, Grigsby SJ, Philips JA. Immune evasion and provocation by Mycobacterium tuberculosis. Nat Rev Microbiol. 2022, 20:750-66. 10.1038\/s41579-022-00763-4","journal-title":"Nat Rev Microbiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24065202","article-title":"Tuberculosis: pathogenesis, current treatment regimens and new drug targets","volume":"24","author":"Alsayed SS","year":"2023","unstructured":"Alsayed SS, Gunosewoyo H. Tuberculosis: pathogenesis, current treatment regimens and new drug targets. Int J Mol Sci. 2023, 24:10.3390\/ijms24065202","journal-title":"Int J Mol Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0218905","article-title":"HIV infection does not alter interferon \u03b1\/\u03b2 receptor 2 expression on mucosal immune cells","volume":"15","author":"Ickler J","year":"2020","unstructured":"Ickler J, Francois S, Widera M, Santiago ML, Dittmer U, Sutter K. HIV infection does not alter interferon \u03b1\/\u03b2 receptor 2 expression on mucosal immune cells. PLoS One. 2020, 15:e0218905. 10.1371\/journal.pone.0218905","journal-title":"PLoS One"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/cells9010254","article-title":"Sensor sensibility-HIV-1 and the innate immune response","volume":"9","author":"Yin X","year":"2020","unstructured":"Yin X, Langer S, Zhang Z, Herbert KM, Yoh S, K\u00f6nig R, Chanda SK. Sensor sensibility-HIV-1 and the innate immune response. Cells. 2020, 9:10.3390\/cells9010254","journal-title":"Cells"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.nic.2022.07.014","article-title":"Human immunodeficiency virus: opportunistic infections and beyond","volume":"33","author":"Siripurapu R","year":"2023","unstructured":"Siripurapu R, Ota Y. Human immunodeficiency virus: opportunistic infections and beyond. Neuroimaging Clin N Am. 2023, 33:147-65. 10.1016\/j.nic.2022.07.014","journal-title":"Neuroimaging Clin N Am"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/s151027160","article-title":"Interferon (IFN) and cellular immune response evoked in RNA-pattern sensing during infection with hepatitis C virus (HCV)","volume":"15","author":"Nakai M","year":"2015","unstructured":"Nakai M, Oshiumi H, Funami K, Okamoto M, Matsumoto M, Seya T, Sakamoto N. Interferon (IFN) and cellular immune response evoked in RNA-pattern sensing during infection with hepatitis C virus (HCV). Sensors (Basel). 2015, 15:27160-73. 10.3390\/s151027160","journal-title":"Sensors (Basel)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/cells8040317","article-title":"Restoration of HCV-specific immune responses with antiviral therapy: a case for DAA treatment in acute HCV infection","volume":"8","author":"Casey JL","year":"2019","unstructured":"Casey JL, Feld JJ, MacParland SA. Restoration of HCV-specific immune responses with antiviral therapy: a case for DAA treatment in acute HCV infection. Cells. 2019, 8:10.3390\/cells8040317","journal-title":"Cells"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/nri2524","article-title":"B cells in HIV infection and disease","volume":"9","author":"Moir S","year":"2009","unstructured":"Moir S, Fauci AS. B cells in HIV infection and disease. Nat Rev Immunol. 2009, 9:235-45. 10.1038\/nri2524","journal-title":"Nat Rev Immunol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v9.i29.8749","article-title":"Chronic hepatitis-C infection in COVID-19 patients is associated with in-hospital mortality","volume":"9","author":"Ronderos D","year":"2021","unstructured":"Ronderos D, Omar AM, Abbas H, et al.. Chronic hepatitis-C infection in COVID-19 patients is associated with in-hospital mortality. World J Clin Cases. 2021, 9:8749-62. 10.12998\/wjcc.v9.i29.8749","journal-title":"World J Clin Cases"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1198","article-title":"Risk factors for coronavirus disease 2019 (COVID-19) death in a population cohort study from the Western Cape Province, South Africa","volume":"73","year":"2021","unstructured":"Risk factors for coronavirus disease 2019 (COVID-19) death in a population cohort study from the Western Cape Province, South Africa. Clin Infect Dis. 2021, 73.e2005-15. 10.1093\/cid\/ciaa1198","journal-title":"Clin Infect Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S433695","article-title":"Drug-resistant TB, HIV and Covid-19 co-infection: case reviews from Kwa-Zulu Natal, South Africa","volume":"16","author":"Hassan-Moosa R","year":"2023","unstructured":"Hassan-Moosa R, Motsomi KW, Narasimmulu R, et al.. Drug-resistant TB, HIV and Covid-19 co-infection: case reviews from Kwa-Zulu Natal, South Africa. Infect Drug Resist. 2023, 16:7663-70. 10.2147\/IDR.S433695","journal-title":"Infect Drug Resist"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1177\/20499361211016973","article-title":"The impact of COVID-19 on tuberculosis: challenges and opportunities","volume":"8","author":"Kant S","year":"2021","unstructured":"Kant S, Tyagi R. The impact of COVID-19 on tuberculosis: challenges and opportunities. Ther Adv Infect Dis. 2021, 8:20499361211016973. 10.1177\/20499361211016973","journal-title":"Ther Adv Infect Dis"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25568","article-title":"Patterns of HIV and SARS-CoV-2 co-infection in Wuhan, China","volume":"23","author":"Guo W","year":"2020","unstructured":"Guo W, Ming F, Feng Y, et al.. Patterns of HIV and SARS-CoV-2 co-infection in Wuhan, China. J Int AIDS Soc. 2020, 23:e25568. 10.1002\/jia2.25568","journal-title":"J Int AIDS Soc"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1424374","article-title":"Protective interplay: Mycobacterium tuberculosis diminishes SARS-CoV-2 severity through innate immune priming","volume":"15","author":"Williams BD","year":"2024","unstructured":"Williams BD, Ferede D, Abdelaal HF, et al.. Protective interplay: Mycobacterium tuberculosis diminishes SARS-CoV-2 severity through innate immune priming. Front Immunol. 2024, 15:1424374. 10.3389\/fimmu.2024.1424374","journal-title":"Front Immunol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1254206","article-title":"Immune interaction between SARS-CoV-2 and Mycobacterium tuberculosis","volume":"14","author":"Booysen P","year":"2023","unstructured":"Booysen P, Wilkinson KA, Sheerin D, Waters R, Coussens AK, Wilkinson RJ. Immune interaction between SARS-CoV-2 and Mycobacterium tuberculosis. Front Immunol. 2023, 14:1254206. 10.3389\/fimmu.2023.1254206","journal-title":"Front Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/293381-immunological-enigma-a-case-report-of-covid-19-survival-in-a-patient-with-human-immunodeficiency-virus-hepatitis-c-virus-and-tuberculosis-co-infection","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T16:28:55Z","timestamp":1726590535000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/293381-immunological-enigma-a-case-report-of-covid-19-survival-in-a-patient-with-human-immunodeficiency-virus-hepatitis-c-virus-and-tuberculosis-co-infection"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,17]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.69588","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,17]]}}}